Dexras1 mediates glucocorticoid-associated adipogenesis and diet-induced obesity

Jiyoung Y Cha1, Hyo Jung Kim, Jung Hwan Yu

  • 1The Solomon H. Snyder Department of Neuroscience and Departments of Psychiatry and Behavioral Sciences and Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.

Insights

Dexras1 protein mediates fat cell formation (adipogenesis) and diet-induced obesity. Its absence reduces adiposity and weight gain, highlighting its role in metabolic disease.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Metabolic Research

Background:

  • Adipogenesis, the process of fat cell development, is linked to obesity and influenced by glucocorticoids through unclear pathways.
  • Dexras1, a Ras family small G protein, is significantly induced by the synthetic glucocorticoid dexamethasone.

Purpose of the Study:

  • To investigate the role of Dexras1 in mediating adipogenesis and diet-induced obesity.
  • To elucidate the mechanism by which glucocorticoids regulate fat cell differentiation.

Main Methods:

  • Utilizing 3T3-L1 cells to study adipogenesis with Dexras1 depletion and overexpression.
  • Employing mouse embryonic fibroblasts from Dexras1-deleted mice.
  • Analyzing adiposity and diet-induced weight gain in wild-type and Dexras1-deleted mice.

Main Results:

  • Dexras1 depletion abolished adipogenic differentiation in 3T3-L1 cells.
  • Overexpression of Dexras1 promoted adipogenesis.
  • Adipogenesis was significantly reduced in Dexras1-deleted mouse embryonic fibroblasts.
  • Mutant mice exhibited diminished adiposity and reduced weight gain upon high-fat diet.

Conclusions:

  • Dexras1 is a key mediator of adipogenesis and diet-induced obesity.
  • Targeting Dexras1 may offer a therapeutic strategy for obesity and related metabolic disorders.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K